STEMRIM |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 470 JPY | -1.88% |
|
-0.63% | -18.69% |
| 03:13pm | StemRIM to Seek Shareholders' Approval on Capital Stock Reduction | MT |
| 03-13 | StemRIM Announces Initiation of Phase 2 Clinical Trial for Redasemtide in Ischemic Cardiomyopathy | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- 4599 Stock
- Revisions StemRIM
